Skip to main content

Biogen Tanks, Drags Down Biotechnology Sector ETFs

Biotechnology sector-related ETFs took a blow Thursday after drugmaker Biogen (NasdaqGS: BIIB) and Eisai Co. revealed they are ending two late-stage trials for experimental Alzheimer’s therapy. The iShares Nasdaq Biotechnology ETF (NASDAQGM: IBB), the largest biotech exchange traded fund by...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.